Why the study?
Does a polycarbonaturethane bileaflet heart valve prosthesis improve hemodynamic performance and durability compared to commercial bioprostheses in the mitral position in growing calves?
Population
14 growing Jersey calves (age 3-5 months, weight 60-97 kg)
Comparison
Polycarbonaturethane bileaflet heart valve… vs Commercial bioprostheses implanted in mitral…
Design
Preclinical
Follow-up
up to 20 weeks
Authors
Loading...
PCU valves merit further development; extends preclinical durability data in calves but leaves open human translation and requires clinical trials.
Does a polycarbonaturethane bileaflet heart valve prosthesis improve hemodynamic performance and durability compared to commercial bioprostheses in the mitral position in growing calves?
A novel polycarbonaturethane mitral valve prosthesis demonstrated superior in vivo durability and hemodynamic performance with less calcification compared to commercial bioprostheses in a calf model.
Daebritz et al. (2003) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: